Nordic Nanovector ASA has appointed Christine Wilkinson Blanc as chief medical officer to help it advance its portfolio of targeted cancer therapies. Dr Wilkinson Blanc has been medical director of the consultancy Phi-Medics for 10 years helping advise companies on oncology and haematology issues. Prior to this, she was chief medical officer of Psioxus Therapeutics Ltd which is developing oncolytic virus therapies for cancer. Dr Wilkinson Blanc gained her medical qualification, as well as a specialty in medical biology, at medical schools in Lille and Lyon, France.
Nordic Nanovector announced the appointment on 10 August 2020.
Copyright 2020 Evernow Publishing Ltd